Claims
- 1. A pharmaceutical composition comprising a granule comprised of ibuprofen and a narcotic analgesic in a single phase.
- 2. The composition as recited in claim 1 further comprising a blend of the granule and extra granule material.
- 3. A tablet composition comprising the compressed composition of claim.
- 4. A pharmaceutical tablet composition comprising:
(a) an effective amount of ibuprofen; (b) an effective amount of a narcotic analgesic; (c) colloidal silicon dioxide wherein the weight of the colloidal silicon dioxide is provided in a range, of the total weight of the tablet, of about 0.5% to about 3%; (d) a filler selected from the group consisting of microcrystalline cellulose and powdered cellulose; (e) a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, and sodium starch glycolate; (f) a binder consisting of an akylhydroxy methylcellulose wherein the weight of the binder is provided in a range, of the total weight of the tablet composition, of about 2% to less than 6%; (g) a starch provided in a weight range, of total weight of the tablet composition, of about 11% to about 28%; and (h) a lubricant wherein the lubricant is provided in an amount less than 1% by weight of the total weight of the tablet; wherein the tablet comprises a compressed blend of a granule and extra granule material wherein the granule comprises at least a portion of the ibuprofen, at least a portion of the narcotic analgesic, a portion of the colloidal silicon dioxide, a portion of the disintegrant, and a portion of the starch and the weight of the extra granule material is provided in a range of up to about 25% of the weight of the whole tablet.
- 5. The composition as recited in claim 4 wherein the weight of the filler is provided in a range, of the total weight of the tablet composition, of about 10% to about 42%.
- 6. The composition as recited in claim 4 wherein the weight of the disintegrant is provided in a range, of the total weight of the tablet composition, of about 4% to about 10%.
- 7. The composition as recited in claim 5 wherein the weight of the disintegrant is provided in a range, of the total weight of the tablet composition, of about 4% to about 10%.
- 8. A pharmaceutical tablet composition comprising:
(a) an effective amount of ibuprofen wherein the weight of the ibuprofen is provided in a range, of the total weight of the tablet composition, of up to about 50%; (b) an effective amount of hydrocodone; (c) colloidal silicon dioxide provided in a range, by total weight of the tablet composition, of about 1.5% to about 2%; (d) microcrystalline cellulose provided in a range, of the total weight of the tablet composition, of about 15% to about 25%.; (e) a disintegrant selected from the group consisting of croscarmellose sodium and crospovidone wherein the weight of the disintegrant is provided in a range, of the total weight of the tablet composition, of about 6 to about 8%. (f) a binder consisting of an akylhydroxy methylcellulose wherein the weight of the binder is provided in a range, of the total weight of the tablet composition, of about 3% to about 4%; (g) corn starch wherein the weight of the corn starch is provided in a range, of the total weight of the tablet composition, of about 11 to about 17%; and (h) a lubricant wherein the weight of the lubricant is provided in an amount less than 1% by weight of the total weight of the tablet;
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Application No. 60/019687 filed on Jun. 10, 1996.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60019687 |
Jun 1996 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
08872216 |
Jun 1997 |
US |
Child |
10027248 |
Dec 2001 |
US |